Solaci at EuroPCR. Complex left main PCI Patient presentation

Slides:



Advertisements
Similar presentations
Case History 1 : Sorting out chest pain in general practice Dr Albert Ko / GP Panel.
Advertisements

Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
A.Abdi,M.D. Initial Diagnosis Symptoms ECG Cardiac Biomarkers.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Referring in to the Chest pain pathway: The Primary Assessment Dr Ivan Benett 3/22/2011Dr Ivan Benett GPwSI Cardiology.
Ischemic Heart Diseases IHD
Anterior Depressions Angiographic and Clinical Outcomes Among Patients with Acute Coronary Syndromes Presenting with Anterior ST-Segment Depressions C.
‘Taxi Driver in Pain’ Tiara Gill Carrie Ross Mark Hambly.
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
Dr Jayachandran Thejus.  Coronary artery disease-  Block in coronary artery due to plaque or thrombus  Leads to myocardial ischemia manifested as chest.
Management of Stable Angina SIGN 96
Clinical case no. 22 Presenter: Lin,Huei-Hsiu (Caroline) (Caroline)
Management of Chronic Stable Angina AIMGP Seminar Series Mirek Otremba 2007.
Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.
DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.
VULNERABLE PLAQUES: Pertinent doubts and solutions in interventional cardiology EuroPCR Paris, 16 May 2006.
Stress testing patients on oral dipyridamole Dr Parthi Arumugam Consultant Nuclear Physician Nuclear Medicine Centre Manchester Royal Infirmary.
ARMYDA-4 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study Prospective, multicenter, randomized, double blind trial investigating.
Jie Qian National Heart Center & FuWai Hospitall FFR in Diffuse Multivessel Disease.
One patient, two years, three choices, four PCI ZHAO Peng Cardiology , the Affiliated Hospital of Medical College of CPAPF, Tianjin, China.
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Acute Coronary Syndrome David Aymond, MD. ACS Definition: Myocardial ischemia typically due to atherosclerotic plaque rupture  Coronary thrombosis ACS.
Case I A 47 old male presents to your office for a yearly checkup. He smokes 40 cigarette/day, and examination detect wheezy chest and bronchospasm. His.
Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
Gregg W. Stone MD for the ACUITY Investigators Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary.
Relapsing Polychondritis Rupesh Agrawal, Carlos Pavesio Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
Cardiac update for GPs - Chest pain/angina Sanjay Sastry Consultant Cardiologist Royal Bolton Hospital Royal Bolton Hospital Manchester Heart Centre Wigan.
Dr.Ali Eshraghi MD Interventional Cardiologist Non STE ACS  Angiographic Findings: 34% 3VD 28%2VD 26%SVD 10%LMCAD Culprit lesion charactristic: eccentric,scalloped,evidence.
Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary Syndromes Final One-Year Results from the.
Rapid assessment of chest pain Dr Phil Avery Prince Philip Hospital Hywel Dda Health Board PCCS 18 th May 2011.
Duration Safety and Efficacy of Bivalirudin in patients undergoing PCI: The impact of duration of infusion in ACUITY trial Dr. David Cox Lehigh Valley.
Coronary Artery Disease Po Hu IMG 310 Sectional Anatomy for Medical Imaging Summer Pathology Presentation Project.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
Bivalirudin Monotherapy Improves 30-day Clinical Outcomes in Diabetics with Acute Coronary Syndrome: Report from the ACUITY Trial Frederick Feit, Steven.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
August 9th 2016 Structural Heart Live: ND, 89 yr.F
Adel Gamal, MD and Mohamed Saber, Msc
Nightmares in the Cath Lab
Risk Stratification of Chest Pain: Best Practices
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
CORONARY ARTERY DISEASE
Complex Coronary intervention
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
The Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel
Acute and Mid-Term Outcomes of Coronary Stent Implantation for the Treatment of Unprotected Left Main Coronary Artery Disease Dr mahmoud ebrahimi Dr hosein.
Meruzhan Saghatelyan, MD, Interventional cardiologist
Long-Term Forecasting and Comparison of Mortality in the Evaluation of the Xience Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness.
Diagnostic characteristics and prognoses of primary-care patients referred for clinical exercise testing: a prospective observational study Nilsson G1,
9:00 AM-9:05 AM, Tuesday, Oct. 31; Room 201/203
The European Society of Cardiology Presented by Dr. Saman Rasoul
PCI in patients with cardiogenic shock associated with acute occlusion of the left main coronary artery.
Interesting Case Review
Dr. Harvey White on behalf of the ACUITY investigators
Unstable Angina and Non–ST Elevation Myocardial Infarction
Giuseppe Biondi Zoccai, MD
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting.
on behalf of the ACUITY investigators
What oral antiplatelet therapy would you choose?
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Long Term Clinical Results from the Endeavor Program: 5-Year Follow up
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Angioplasty Balloon-associated Coronary Debris and the EZ FilterWire
Train-the-Trainer Cases
Train-the-Trainer Cases
Train-the-Trainer Cases
Presentation transcript:

Solaci at EuroPCR. Complex left main PCI Patient presentation

Complex eft main bifurcation PCI Male, VZM, 54 Risk factors DM2 (insulin-dependent) Hyperlipidaemia Smoker Life style Active Psychological status Normal, no cognitive impairment

No Prior clinical history Clinical presentation One month history of episodes of chest pain at rest and during exertion (15-20 min) Admitted after an episode of chest pain at rest with no dynamic ECG changes

Laboratory investigations Biomarkers: TnI: <0.01, CK: 130 (1st ) TnI: <0.01, CK: 113 (2nd) Creatinine: 0.88 gr/dl Clearance creatinine: 97 ml/min Hb: 16 gr/dl Platelets: 194 000 Total cholesterol: 217 gr/dl HDLc: 33 gr/dl LDLc: 44.4 gr/dl

Non-invasive evaluation ECG: sinus rythm, 75 bpm, normal repolarisation Exercise test: ECG positive with ST depression in inferior leads. Clinically

Baseline angiography Medina 0-1-0 Please select the best stop frame image: no AVI’s please, 2 images max

Baseline angiography

Risk evaluation Angiographic Syntax score = 12 Syntax score II: PCI: 18.0 (PCI 4 Year Mortality: 2.5 %) CABG: 16.2 (CABG 4 Year Mortality: 2.2 %)    Treatment recommendation: equipoise for CABG or PCI STS score = 0.362 EuroSCORE (mortality logistic) = 1.54

Key clinical data & angiographic reference 54 year old male. Diabetic, smoker. Progressive angina with positive exercise test . Severe stenosis ostial LAD